AM Bottleneck Brief #2 · Research cutoff: September 12, 2026
CT / NDT throughput as the release gate
For many qualified metal AM routes, accepted-part release is limited by inspection/NDT capacity and locked acceptance criteria—not by printer speed.
Extends Brief #1 — Why Scale Fails After the Print. Company names below are bottleneck-exposure mappings only, not investment advice.
Short answer
X-ray CT is often the binding method for complex internal geometry, but CT is not a universal filter: detectability depends on material, thickness, defect morphology, scan/reconstruction settings and validated POD. Monitoring does not replace CT/DT by default.
A finished build is not a released part. Release waits on inspectability, disposition rules and queue time.
1. The bottleneck
Brief #1 framed the industrial metric correctly:
Accepted output ≈ print capacity × availability × print yield × downstream yield × release rate.
This brief isolates bottleneck #5 on the Addithive Atlas: Inspection, NDT and acceptance criteria. After print—and often after stress relief, HIP, machining and cleaning—the route still stops if there is no validated method, no accepted disposition criteria, or approved CT/NDT capacity is scarce relative to build volume.
| Failure mode | What breaks | Evidence to track |
|---|---|---|
| Method gap | Critical defects not covered | Inspection plan vs FMEA; POD status |
| Criteria gap | Findings without accept/reject rules | Open MRBs; disposition backlog |
| Capacity gap | Queue dominates | CT turnaround; scanner utilization |
| False-call / over-reject | Throughput collapses | False-call rate; repeat scans |
| Substitution overclaim | Monitoring treated as CT replacement | Approved substitution list |
Standing refusal: Voxel size is not the minimum detectable defect size. A successful demo scan is not serial inspection readiness.
2. The evidence
Standards and qualification
| Source | What it anchors | Boundary |
|---|---|---|
| ISO/ASTM 52908:2023 | Post-processing, inspection and testing for metal PBF | Framework ≠ part-specific criteria |
| ISO/ASTM 52920:2023 | Site QA measures across industrial AM | Site QA ≠ flight/clinical approval |
| NASA-STD-6030 / 6033 | Flight hardware + facility control (6033 revalidated Jan 2026) | Agency-specific mental model |
Technical evidence
- CT is uniquely useful for 3D internal inspection of complex AM geometry; it is not universally superior to UT, PT, ET or radiography.
- Recent literature supports the detectability boundary: Sun et al. (2024) review XCT across prevention, diagnosis and failure prediction in metal AM; Baig et al. (2025) show XCT performance deteriorates more for irregular lack-of-fusion defects than for near-spherical pores, with reliable capture often needing features several times larger than a voxel. Separately, a 2024 Ti-6Al-4V POD study found high detection rates can require flaw sizes substantially larger than nominal voxel size.
Decision rule: describe detectability with material, thickness, morphology/orientation, scan/reconstruction settings and POD basis—or do not claim a detection limit.
Monitoring does not erase the release gate
NIST framing and Addithive’s substitution brief converge: telemetry ≠ sensing ≠ post-process NDT/CT ≠ destructive testing. A melt-pool image is not a pore measurement. Substitution needs measurand definition, registration, ground truth, POD, false-call behavior, robustness, locked analytics and approval—layered evidence, not automatic elimination of post-build inspection.
Industrial signals (commercial, labeled)
| Signal | Status | Why it maps here |
|---|---|---|
| Bodycote U.S. east-network HIP/HT/wire EDM for printed metal | ~21 Jul 2026 | Downstream capacity; inspection release remains separate |
| Hexagon to acquire Waygate (~$1.45B; 2D X-ray / 3D CT, RVI, UT) | Announced 13 Apr 2026; still pending as of 12 Sep 2026 — expected close H2 2026; no completion announced | Capital to NDT hardware + CT stack beside metrology/CT analysis |
| America Makes JAQS-SQ; U.S.–UK AAMI | 2026 | NDT, acceptance criteria, portable evidence as scale constraints |
Update, 28 October 2026: Hexagon’s acquisition of Waygate Technologies is still pending; no completion has been announced. In its Q3 2026 interim report (23 October 2026), Hexagon said the deal “remains on track to complete in Q4 2026.” The table above has not been updated.
Commercial signal ≠ proof that any vendor resolves AM CT throughput industry-wide.
3. The exposed companies
Mapping only—not investment advice. AM materiality is often emerging or immaterial at group level.
| Role | Public exposures (map) | Analyze (not “buy”) |
|---|---|---|
| CT / NDT systems | Hexagon (VG; pending Waygate), Nikon, ZEISS; Waygate/Baker Hughes until close | Capacity, AM apps, software attach, integration risk |
| Metrology / simulation adjacent | Hexagon, AMETEK (FARO/Creaform), Renishaw; Simufact / Ansys / Siemens / Dassault | Whether dimensional or predicted risk sits on the release path |
| Depends on CT to ship / densification | Aerospace/defense adopters; ATI; Oerlikon; Bodycote (HIP) | Internal-channel families; CT vs print queue; HIP ≠ inspection release |
4. The decision
What changed
- Inspection/NDT is the explicit release-rate limiter for complex accepted-part output.
- Hexagon’s Waygate deal elevates NDT/CT strategically (close still pending as of 12 Sep 2026; H2 2026 target unchanged).
- Defense work treats NDT + acceptance criteria + portable evidence as infrastructure.
What remains unproven
- Whether automated CT review materially raises accepted-part throughput without missed-defect risk in regulated apps.
- Whether in-situ monitoring wins approved substitution on flight/clinical hardware at scale.
- Whether NDT M&A shortens customer queue time or mainly consolidates share.
What to watch
- CT turnaround/utilization at qualified labs (not demo times).
- POD / locked acceptance criteria for LPBF Ti and Ni.
- Count of approved monitoring substitutions.
- False-call and MRB rates after CT.
- Waygate close and any disclosed aerospace/AM CT backlog (H2 2026).
- Accepted-part yield vs build-success rate.
Decision rule
Before buying another printer, ask: critical defect population? Validated NDT/CT + POD? Locked acceptance criteria? Approved inspection capacity vs build volume? Approved monitoring substitution—or only complementary evidence? If the queue sits at CT/NDT disposition, more print capacity increases WIP, not shipments.
Sources
- Addithive: Brief #1; CT vs NDT; Monitoring substitution; Aerospace qualification; Bottleneck companies
- ISO/ASTM 52908:2023 (current ed., iso.org stage 60.60); ISO/ASTM 52920:2023; NASA-STD-6030 / 6033
- Sun et al. (2024), Thin-Walled Structures — XCT metal AM review; Baig et al. (2025), Scientific Reports 15:6740 — irregular LoF detectability; 2024 Ti-6Al-4V POD literature — high detection often requires flaws ≫ voxel
- Hexagon / Baker Hughes Waygate announcement 13 Apr 2026; re-checked 12 Sep 2026 — close still pending (H2 2026)
- Bodycote eastern U.S. AM post-processing (Jul 2026); America Makes JAQS-SQ / AAMI (2026)
Continue the bottleneck research
Download the free Industrial AM Bottleneck Atlas and receive one evidence-led bottleneck brief each week.
Related: Research Hub · Tools · CT vs conventional NDT · Qualification Evidence Checklist · Brief #1.
Addithive provides engineering-led research mapping. This article is not engineering certification, legal advice or investment advice.

Leave a Reply